Aim of the webinar:
Asian-type DEL is the most prevalent DEL variant worldwide with more than two million carriers of this phenotype. It has been the hypothesis for almost 20 years that Asian-type DEL patients should be treated as RhD-positive individuals. The publication that is going to be addressed during the Live Journal Club provides more data to support the application of RhD-positive blood transfusion in Asian-type DEL patients.
Level of education required:
Level 3 - Intermediate (practical application)
What prior knowledge is required to attend the webinar?
Participants are recommended to read the following publication:
Target audience:
Scientists, blood bankers, transfusion practitioners, technicians and graduate students with an interest in blood group research.
The speaker:
Yanli Ji
Regional Director Western Pacific (2024-2028)
Yanli Ji start to work in the Institute of Clinical Blood Transfusion in Guangzhou Blood Center since she got the PhD degree in 2008 from Sun Yat-Sen University in China till now. From 2010 to 2011, she worked as a visiting scholar in Sanquin Research. Her interests are the research of RBC blood group genotyping and its application in the Chinese population, rare donor program, blood group reference testing, and clinical consults. The routine Asian-type DEL testing was firstly carried out in their lab to avoid anti-D prophylaxis in Asian-type DEL pregnant women in China. She was a member of the first ISBT young professional council. Now she is a member of ISBT working party of Red Cell Immunogenetics and Blood Group Terminology, and the vice director of immunohematology Committee of CSBT (Chinese Society of Blood Transfusion).
Do you have a question for Yanli? Fill in the form below.
The moderator:
Ping Chun (Gloria) Wu
Don't miss out register now to secure your spot at the webinar!
